Bach Paul David 4
4 · Genesis Healthcare, Inc. · Filed Jun 7, 2018
Insider Transaction Report
Form 4
Transactions
- Sale
Class A Common Stock
2018-06-05$2.19/sh−10,131$22,200→ 571,140 total - Award
Class A Common Stock
2018-06-06+185,900→ 757,040 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected to satisfy the reporting person's income tax obligations with respect to the vesting of a restricted stock unit award.
- [F2]Includes 212,332 unvested restricted stock units that have not yet been paid in shares of the Issuer's Class A Common Stock.
- [F3]Grant of restricted stock units under the Issuer's 2015 Omnibus Equity Incentive Plan.
- [F4]Includes 398,232 unvested restricted stock units that have not yet been paid in shares of the Issuer's common stock.